Patent · US Active

VEGFR3 inhibitors

US9238644B2 · kind B2 · utility

0Cited by

0References

61Claims

0Family size

Assignee

Cancer Therapeutics CRC Pty Ltd · AU

Inventors

Richard Charles Foitzik · Elmore, AU
Benjamin Joseph Morrow · Melbourne, AU
Catherine Fae Hemley · Melbourne, AU
Gillian Elizabeth Lunniss · Melbourne, AU
Michelle Ang Camerino · Melbourne, AU
Danny Ganame · Melbourne, AU
Paul Anthony Stupple · Melbourne, AU
Romina Lessene · Melbourne, AU
Wilhelmus Johannes Antonius Kersten · Melbourne, AU
Andrew John Harvey · Adelaide, AU
Ian Holmes · Melbourne, AU

Key dates

Filing date	Aug 16, 2013
Grant date	Jan 19, 2016
Priority date	—
Expiry date	Aug 16, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a compound of the formula (I):The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer, as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphangiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.